This company has been marked as potentially delisted and may not be actively trading. NYSE:EXAM (EXAM) (EXAM) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About (EXAM) Stock (NYSE:EXAM) 30 days 90 days 365 days Advanced Chart Get (EXAM) alerts:Sign Up Key Stats Today's Range$35.05▼$35.1750-Day Range N/A52-Week Range$21.98▼$37.26Volume3.56 million shsAverage Volume660,679 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.Read More… Receive EXAM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (EXAM) and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAM Stock News HeadlinesNEET-PG aspirants from Kashmir urge NBE to increase exam centres in the valleyJune 3 at 10:59 AM | msn.comNEET-PG 2025: NBEMS seeks SC’s nod to conduct exam on August 3 after postponementJune 3 at 10:59 AM | msn.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.June 3, 2025 | Porter & Company (Ad)TG ICET 2025: Admit card released for exam on June 8-9. DETAILS here.June 3 at 5:58 AM | msn.comMore than 200 California bar exam-takers move from fail to pass after new scoring adjustmentJune 3 at 5:58 AM | msn.comPlus-I exam pass rate dips by 5% to settle at 62.28% in KeralaJune 3 at 12:40 AM | msn.comSBI Clerk Mains Exam 2025: Are Results Out? Know Key Details HereJune 3 at 12:40 AM | msn.comNEET PG Exam 2025 postponed until further notice: NBE to announce fresh dates shortly, check details hereJune 2 at 2:38 PM | msn.comSee More Headlines EXAM Stock Analysis - Frequently Asked Questions How were (EXAM)'s earnings last quarter? (EXAM) (NYSE:EXAM) released its earnings results on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share for the quarter, hitting the consensus estimate of $0.08. (EXAM)'s revenue for the quarter was up 15.4% on a year-over-year basis. What other stocks do shareholders of (EXAM) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (EXAM) investors own include Bristol-Myers Squibb (BMY), Ciena (CIEN), Best Buy (BBY), China Biologic Products (CBPO), Community Health Systems (CYH), Diplomat Pharmacy (DPLO) and Energy Transfer (ET). Company Calendar Last Earnings5/10/2016Today6/03/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Services Current SymbolNYSE:EXAM CIK1498021 Webwww.examworks.com Phone+1-404-9522400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:EXAM) was last updated on 6/3/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (EXAM) Please log in to your account or sign up in order to add this asset to your watchlist. Share (EXAM) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.